These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 38536646)

  • 1. Impact of Immunosuppressed Status on Prognosis of Carbapenem-Resistant Organisms Bloodstream Infections.
    Li YY; Chen Y; Li S; Li YY; An R; Hu XY; Jiang W; Wang CY; Dong R; Yang QW; Weng L; Peng JM; Du B
    Infect Dis Ther; 2024 Apr; 13(4):861-874. PubMed ID: 38536646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rectal culture could predict carbapenem-resistant organism bloodstream infection and reduce the mortality in haematological patients: A retrospective cohort study.
    Gao S; Yan R; Zhang S; Li L; Zhang R; Fan J; Qin J; Peng Y; Wan D; Cao W; Bian Z
    J Glob Antimicrob Resist; 2024 Mar; 36():96-104. PubMed ID: 38128727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of carbapenem-resistant gram-negative bacterial bloodstream infection in patients with end-stage renal disease in intensive care units: a multicenter retrospective observational study.
    Lin YC; Yang KY; Peng CK; Chan MC; Sheu CC; Feng JY; Wang SH; Huang WH; Chen CM; Chen DH; Chen CL;
    Infection; 2024 Jul; ():. PubMed ID: 38995550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Risk Factors of Carbapenem-Resistant Gram-Negative Bacteria Bloodstream Infection in Immunosuppressed Patients: A 7-Year Retrospective Cohort Study.
    Gao Y; Lin H; Xu Y; Yao Y; Shi D; Li J; Zhu H; Summah HD; Ni L; Feng Y
    Infect Drug Resist; 2022; 15():6451-6462. PubMed ID: 36349216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Outcomes of Carbapenem-resistant Bloodstream Infection in Children With Cancer.
    Nirmal G; Jithin TK; Gopakumar KG; Parthiban R; Nair C
    J Pediatr Hematol Oncol; 2023 Aug; 45(6):e678-e682. PubMed ID: 37146155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary-care hospital in China: an eight-year retrospective study.
    Chen J; Ma H; Huang X; Cui Y; Peng W; Zhu F; Ma S; Rao M; Zhang P; Yang H; Su L; Niu R; Pan P
    Antimicrob Resist Infect Control; 2022 Dec; 11(1):161. PubMed ID: 36536423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Effective Antimicrobial Regimens and Mortality-Related Risk Factors for Bloodstream Infections Caused by Carbapenem-Resistant
    Gu S; Xiong J; Peng S; Hu L; Zhu H; Xiao Y; Luo H; Hang Y; Chen Y; Fang X; Cao X; Fang Y; Li F; Zhu J; Zhong Q
    Infect Drug Resist; 2023; 16():2589-2600. PubMed ID: 37152405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Impact of Ceftriaxone Resistance in
    Tamma PD; Komarow L; Ge L; Garcia-Diaz J; Herc ES; Doi Y; Arias CA; Albin O; Saade E; Miller LG; Jacob JT; Satlin MJ; Krsak M; Huskins WC; Dhar S; Shelburne SA; Hill C; Baum KR; Bhojani M; Greenwood-Quaintance KE; Schmidt-Malan SM; Patel R; Evans SR; Chambers HF; Fowler VG; van Duin D;
    Open Forum Infect Dis; 2022 Nov; 9(11):ofac572. PubMed ID: 36381622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality associated with carbapenem resistance in
    Wang L; Zeng C; Li X; Li Y; Liu Z; Hu J
    Infect Control Hosp Epidemiol; 2024 Mar; ():1-8. PubMed ID: 38487826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical Characteristics and Risk Factors for 30-Day Mortality in Patients with Hematologic Diseases Infected by Carbapenem-Resistant Organisms].
    Chen XY; Hou CR; Zhao J; He SL; Lu XY; Guo XY; Wang RX; Ma LM; Wei JN; Tian WW
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1199-1204. PubMed ID: 37551498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors and Outcomes of Antibiotic-resistant Pseudomonas aeruginosa Bloodstream Infection in Adult Patients With Acute Leukemia.
    Zhao Y; Lin Q; Liu L; Ma R; Chen J; Shen Y; Zhu G; Jiang E; Mi Y; Han M; Wang J; Feng S
    Clin Infect Dis; 2020 Dec; 71(Suppl 4):S386-S393. PubMed ID: 33367574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics, Microbiology, and Risk Factors for Mortality of Pre-Engraftment and Post-Engraftment Bloodstream Infection in Hematopoietic Stem Cell Transplantation Recipients.
    Chen W; Zhao Y; Luo Y; Yu J; Fu H; Lai X; Liu L; Ye Y; He J; Sun J; Zheng W; Zhao Y; Wei G; Cai Z; Huang H; Shi J
    Infect Drug Resist; 2022; 15():6893-6905. PubMed ID: 36465805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of
    Tian L; Tan R; Chen Y; Sun J; Liu J; Qu H; Wang X
    Antimicrob Resist Infect Control; 2016; 5():48. PubMed ID: 27891222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk Factors and Outcomes of Patients with Carbapenem-Resistant
    Wei X; Li L; Li M; Liang H; He Y; Li S
    Infect Drug Resist; 2023; 16():337-346. PubMed ID: 36698726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of antimicrobial therapy duration and class on risk of antimicrobial-resistant Gram-negative bacillus bloodstream infection in patients with AML.
    Huggins J; Barnett I; David MZ
    Transpl Infect Dis; 2023 Dec; 25(6):e14115. PubMed ID: 37577960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Visualized Mortality Prediction Score Model in Hematological Malignancies Patients with Carbapenem-Resistant Organisms Bloodstream Infection.
    Qian C; Wu Q; Ruan Z; Liu F; Li W; Shi W; Ma L; Peng D; Yin H; Yao L; Li Z; Hong M; Xia L
    Infect Drug Resist; 2023; 16():201-215. PubMed ID: 36644657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective comparative analysis of risk factors and outcomes in patients with carbapenem-resistant
    Niu T; Xiao T; Guo L; Yu W; Chen Y; Zheng B; Huang C; Yu X; Xiao Y
    Infect Drug Resist; 2018; 11():2021-2030. PubMed ID: 30464544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five-year change of prevalence and risk factors for infection and mortality of carbapenem-resistant Klebsiella pneumoniae bloodstream infection in a tertiary hospital in North China.
    Li Y; Li J; Hu T; Hu J; Song N; Zhang Y; Chen Y
    Antimicrob Resist Infect Control; 2020 Jun; 9(1):79. PubMed ID: 32487221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors and outcomes of inpatients with carbapenem-resistant
    Yuan Q; Guo L; Li B; Zhang S; Feng H; Zhang Y; Yu M; Hu H; Chen H; Yang Q; Qu T
    Front Microbiol; 2023; 14():1137811. PubMed ID: 37260693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Key microbial monitoring and clinical analysis of bloodstream infections and CRO colonization after hematopoietic stem cell transplantation in hematological patients].
    Zhang A; Qian CJ; Wei RW; Jiang S; Fang J; Shi W; Xia LH
    Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):134-140. PubMed ID: 38604789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.